Calcium urolithiasis course in young stone formers is influenced by the strength of family history: results from a retrospective study

The role of the strength of family history of stones (FHS), i.e., degree of relatives with the disease, on the course of calcium urolithiasis (CU) is not fully understood, particularly in young patients where genetic background has the greatest influence on disease expression. Thus, with a retrospec...

Full description

Saved in:
Bibliographic Details
Published inUrolithiasis Vol. 45; no. 6; pp. 525 - 533
Main Authors Guerra, Angela, Ticinesi, Andrea, Allegri, Franca, Nouvenne, Antonio, Pinelli, Silvana, Lauretani, Fulvio, Maggio, Marcello, Cervellin, Gianfranco, Borghi, Loris, Meschi, Tiziana
Format Journal Article
LanguageEnglish
Published Berlin/Heidelberg Springer Berlin Heidelberg 01.12.2017
Springer Nature B.V
Subjects
Online AccessGet full text
ISSN2194-7228
2194-7236
2194-7236
DOI10.1007/s00240-016-0955-9

Cover

Abstract The role of the strength of family history of stones (FHS), i.e., degree of relatives with the disease, on the course of calcium urolithiasis (CU) is not fully understood, particularly in young patients where genetic background has the greatest influence on disease expression. Thus, with a retrospective cross-sectional design, we examined baseline clinical parameters and urinary chemistries of 369 subjects (196 M) with CU and 96 controls (41 M) aged between 15 and 25 at the time of the first visit at our stone clinic. Subjects with metabolic syndrome traits, known causes of CU or CU onset before the age of 15 were excluded. Clinical and metabolic parameters were compared among stone formers (SF) and controls, stratified by gender, the presence and type of FHS determined through the kinship coefficient of relatives with stones. No significant differences in clinical course were found between SF with and without FHS, except for the presence of bilateral stones (OR 2.01, 95% CI 1.20–3.39, p  < 0.01). A significant age-, sex- and disease duration-adjusted trend for a higher number of colics ( p for trend = 0.001), number of stones ( p for trend = 0.002), stone rate ( p for trend = 0.003) and the presence of retained stones (OR 1.60, 95% CI 1.14–2.21, p  = 0.006) was detected with increasing FHS strength. Urinary chemistries were unaffected by FHS in both SF and controls, except for a higher calcium excretion in females with FHS ( p  < 0.05). The type of FHS, thus, significantly influences the clinical course of CU in young SF, mainly irrespective of urinary factors.
AbstractList The role of the strength of family history of stones (FHS), i.e., degree of relatives with the disease, on the course of calcium urolithiasis (CU) is not fully understood, particularly in young patients where genetic background has the greatest influence on disease expression. Thus, with a retrospective cross-sectional design, we examined baseline clinical parameters and urinary chemistries of 369 subjects (196 M) with CU and 96 controls (41 M) aged between 15 and 25 at the time of the first visit at our stone clinic. Subjects with metabolic syndrome traits, known causes of CU or CU onset before the age of 15 were excluded. Clinical and metabolic parameters were compared among stone formers (SF) and controls, stratified by gender, the presence and type of FHS determined through the kinship coefficient of relatives with stones. No significant differences in clinical course were found between SF with and without FHS, except for the presence of bilateral stones (OR 2.01, 95% CI 1.20-3.39, p < 0.01). A significant age-, sex- and disease duration-adjusted trend for a higher number of colics (p for trend = 0.001), number of stones (p for trend = 0.002), stone rate (p for trend = 0.003) and the presence of retained stones (OR 1.60, 95% CI 1.14-2.21, p = 0.006) was detected with increasing FHS strength. Urinary chemistries were unaffected by FHS in both SF and controls, except for a higher calcium excretion in females with FHS (p < 0.05). The type of FHS, thus, significantly influences the clinical course of CU in young SF, mainly irrespective of urinary factors.
The role of the strength of family history of stones (FHS), i.e., degree of relatives with the disease, on the course of calcium urolithiasis (CU) is not fully understood, particularly in young patients where genetic background has the greatest influence on disease expression. Thus, with a retrospective cross-sectional design, we examined baseline clinical parameters and urinary chemistries of 369 subjects (196 M) with CU and 96 controls (41 M) aged between 15 and 25 at the time of the first visit at our stone clinic. Subjects with metabolic syndrome traits, known causes of CU or CU onset before the age of 15 were excluded. Clinical and metabolic parameters were compared among stone formers (SF) and controls, stratified by gender, the presence and type of FHS determined through the kinship coefficient of relatives with stones. No significant differences in clinical course were found between SF with and without FHS, except for the presence of bilateral stones (OR 2.01, 95% CI 1.20–3.39, p < 0.01). A significant age-, sex- and disease duration-adjusted trend for a higher number of colics (p for trend = 0.001), number of stones (p for trend = 0.002), stone rate (p for trend = 0.003) and the presence of retained stones (OR 1.60, 95% CI 1.14–2.21, p = 0.006) was detected with increasing FHS strength. Urinary chemistries were unaffected by FHS in both SF and controls, except for a higher calcium excretion in females with FHS (p < 0.05). The type of FHS, thus, significantly influences the clinical course of CU in young SF, mainly irrespective of urinary factors.
The role of the strength of family history of stones (FHS), i.e., degree of relatives with the disease, on the course of calcium urolithiasis (CU) is not fully understood, particularly in young patients where genetic background has the greatest influence on disease expression. Thus, with a retrospective cross-sectional design, we examined baseline clinical parameters and urinary chemistries of 369 subjects (196 M) with CU and 96 controls (41 M) aged between 15 and 25 at the time of the first visit at our stone clinic. Subjects with metabolic syndrome traits, known causes of CU or CU onset before the age of 15 were excluded. Clinical and metabolic parameters were compared among stone formers (SF) and controls, stratified by gender, the presence and type of FHS determined through the kinship coefficient of relatives with stones. No significant differences in clinical course were found between SF with and without FHS, except for the presence of bilateral stones (OR 2.01, 95% CI 1.20-3.39, p < 0.01). A significant age-, sex- and disease duration-adjusted trend for a higher number of colics (p for trend = 0.001), number of stones (p for trend = 0.002), stone rate (p for trend = 0.003) and the presence of retained stones (OR 1.60, 95% CI 1.14-2.21, p = 0.006) was detected with increasing FHS strength. Urinary chemistries were unaffected by FHS in both SF and controls, except for a higher calcium excretion in females with FHS (p < 0.05). The type of FHS, thus, significantly influences the clinical course of CU in young SF, mainly irrespective of urinary factors.The role of the strength of family history of stones (FHS), i.e., degree of relatives with the disease, on the course of calcium urolithiasis (CU) is not fully understood, particularly in young patients where genetic background has the greatest influence on disease expression. Thus, with a retrospective cross-sectional design, we examined baseline clinical parameters and urinary chemistries of 369 subjects (196 M) with CU and 96 controls (41 M) aged between 15 and 25 at the time of the first visit at our stone clinic. Subjects with metabolic syndrome traits, known causes of CU or CU onset before the age of 15 were excluded. Clinical and metabolic parameters were compared among stone formers (SF) and controls, stratified by gender, the presence and type of FHS determined through the kinship coefficient of relatives with stones. No significant differences in clinical course were found between SF with and without FHS, except for the presence of bilateral stones (OR 2.01, 95% CI 1.20-3.39, p < 0.01). A significant age-, sex- and disease duration-adjusted trend for a higher number of colics (p for trend = 0.001), number of stones (p for trend = 0.002), stone rate (p for trend = 0.003) and the presence of retained stones (OR 1.60, 95% CI 1.14-2.21, p = 0.006) was detected with increasing FHS strength. Urinary chemistries were unaffected by FHS in both SF and controls, except for a higher calcium excretion in females with FHS (p < 0.05). The type of FHS, thus, significantly influences the clinical course of CU in young SF, mainly irrespective of urinary factors.
The role of the strength of family history of stones (FHS), i.e., degree of relatives with the disease, on the course of calcium urolithiasis (CU) is not fully understood, particularly in young patients where genetic background has the greatest influence on disease expression. Thus, with a retrospective cross-sectional design, we examined baseline clinical parameters and urinary chemistries of 369 subjects (196 M) with CU and 96 controls (41 M) aged between 15 and 25 at the time of the first visit at our stone clinic. Subjects with metabolic syndrome traits, known causes of CU or CU onset before the age of 15 were excluded. Clinical and metabolic parameters were compared among stone formers (SF) and controls, stratified by gender, the presence and type of FHS determined through the kinship coefficient of relatives with stones. No significant differences in clinical course were found between SF with and without FHS, except for the presence of bilateral stones (OR 2.01, 95% CI 1.20–3.39, p  < 0.01). A significant age-, sex- and disease duration-adjusted trend for a higher number of colics ( p for trend = 0.001), number of stones ( p for trend = 0.002), stone rate ( p for trend = 0.003) and the presence of retained stones (OR 1.60, 95% CI 1.14–2.21, p  = 0.006) was detected with increasing FHS strength. Urinary chemistries were unaffected by FHS in both SF and controls, except for a higher calcium excretion in females with FHS ( p  < 0.05). The type of FHS, thus, significantly influences the clinical course of CU in young SF, mainly irrespective of urinary factors.
Author Maggio, Marcello
Ticinesi, Andrea
Allegri, Franca
Pinelli, Silvana
Lauretani, Fulvio
Guerra, Angela
Nouvenne, Antonio
Borghi, Loris
Meschi, Tiziana
Cervellin, Gianfranco
Author_xml – sequence: 1
  givenname: Angela
  surname: Guerra
  fullname: Guerra, Angela
  organization: Geriatric Rehabilitation Department, University-Hospital of Parma, Department of Clinical and Experimental Medicine, University of Parma
– sequence: 2
  givenname: Andrea
  surname: Ticinesi
  fullname: Ticinesi, Andrea
  email: andrea.ticinesi@unipr.it
  organization: Geriatric Rehabilitation Department, University-Hospital of Parma, Department of Clinical and Experimental Medicine, University of Parma
– sequence: 3
  givenname: Franca
  surname: Allegri
  fullname: Allegri, Franca
  organization: Geriatric Rehabilitation Department, University-Hospital of Parma, Department of Clinical and Experimental Medicine, University of Parma
– sequence: 4
  givenname: Antonio
  surname: Nouvenne
  fullname: Nouvenne, Antonio
  organization: Geriatric Rehabilitation Department, University-Hospital of Parma, Department of Clinical and Experimental Medicine, University of Parma
– sequence: 5
  givenname: Silvana
  surname: Pinelli
  fullname: Pinelli, Silvana
  organization: Department of Clinical and Experimental Medicine, University of Parma
– sequence: 6
  givenname: Fulvio
  surname: Lauretani
  fullname: Lauretani, Fulvio
  organization: Geriatric Rehabilitation Department, University-Hospital of Parma
– sequence: 7
  givenname: Marcello
  surname: Maggio
  fullname: Maggio, Marcello
  organization: Geriatric Rehabilitation Department, University-Hospital of Parma, Department of Clinical and Experimental Medicine, University of Parma
– sequence: 8
  givenname: Gianfranco
  surname: Cervellin
  fullname: Cervellin, Gianfranco
  organization: Emergency Department, University-Hospital of Parma
– sequence: 9
  givenname: Loris
  surname: Borghi
  fullname: Borghi, Loris
  organization: Geriatric Rehabilitation Department, University-Hospital of Parma, Department of Clinical and Experimental Medicine, University of Parma
– sequence: 10
  givenname: Tiziana
  surname: Meschi
  fullname: Meschi, Tiziana
  organization: Geriatric Rehabilitation Department, University-Hospital of Parma, Department of Clinical and Experimental Medicine, University of Parma
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27942796$$D View this record in MEDLINE/PubMed
BookMark eNp9kc2KFDEUhYOMOOM4D-BGAm7clCapdKXiThr_YMCNrkMmddOdoSpp8yPUC8xze5ueERnQQEgC37n35pzn5CymCIS85OwtZ0y9K4wJyTrGh47pzabTT8iF4Fp2SvTD2Z-7GM_JVSm3DJfWWnL2jJwLpSXu4YLcbe3sQltoy2kOdR9sCYW61HIBGiJdU4s7Wir2pj7lBXKhCITo5wbRwURvVlr3gEiGuKt7mjz1dgnzSvcBdXl9TzOUNtdCfU4LtfisOZUDuBp-HYVtWl-Qp97OBa7uz0vy49PH79sv3fW3z1-3H6471ytRO9CjUtqBHz0f7QCcuY3qRzkwUE57YS0I6RTC3E_Ww-iZnHpmnZQATvL-krw51T3k9LNBqWYJxcE82wipFcPHjRgGNHBE9PUj9BZdiTid4ej3ZlBKDUi9uqfazQKTOeSw2LyaB4cRUCfA4Z9LBm9cqLaGFGu2YTacmWOc5hSnwTjNMU6jUckfKR-K_08jTpqCbNxB_mvof4p-A0uVs_Q
CitedBy_id crossref_primary_10_1007_s00240_019_01156_8
crossref_primary_10_1371_journal_pone_0213180
crossref_primary_10_1016_j_jpurol_2020_03_014
crossref_primary_10_1007_s00240_018_1097_z
crossref_primary_10_1089_end_2023_0132
crossref_primary_10_4103_UROS_UROS_20_17
crossref_primary_10_1016_j_urols_2017_07_010
Cites_doi 10.1007/s00240-013-0619-y
10.1053/j.ajkd.2004.06.030
10.1016/S0022-5347(17)42497-9
10.1007/s00240-016-0878-5
10.3109/00365590903151479
10.1210/jc.2013-1834
10.1016/j.urology.2012.06.034
10.1016/j.juro.2008.01.011
10.1001/archinte.1982.00340160084019
10.5527/wjn.v3.i4.256
10.1097/01.ju.0000099789.99127.6b
10.1007/s00240-007-0083-7
10.1681/ASN.2013091011
10.1111/j.1523-1755.2005.00170.x
10.1056/NEJM196806132782403
10.1515/cclm-2013-0618
10.1016/S0022-5347(17)54106-3
10.1007/s40620-015-0225-x
10.1007/s40620-016-0329-y
10.1681/ASN.V74608
10.1681/ASN.V8101568
ContentType Journal Article
Copyright Springer-Verlag Berlin Heidelberg 2016
Urolithiasis is a copyright of Springer, 2017.
Copyright_xml – notice: Springer-Verlag Berlin Heidelberg 2016
– notice: Urolithiasis is a copyright of Springer, 2017.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
8AO
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
CCPQU
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
DOI 10.1007/s00240-016-0955-9
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central
ProQuest One
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Pharma Collection
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
ProQuest Health & Medical Research Collection
Health Research Premium Collection
ProQuest Medical Library
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
Health & Medical Research Collection
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Medical Library (Alumni)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE
ProQuest One Academic Middle East (New)
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2194-7236
EndPage 533
ExternalDocumentID 27942796
10_1007_s00240_016_0955_9
Genre Journal Article
GroupedDBID -EM
.VR
06C
06D
0R~
203
29~
2J2
2JN
2JY
2KG
2KM
2LR
3V.
4.4
406
408
40E
53G
5C9
5VS
7X7
88E
8FI
8FJ
8UJ
95-
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABBBX
ABBXA
ABDZT
ABECU
ABFTV
ABHLI
ABHQN
ABIPD
ABJNI
ABJOX
ABKCH
ABKTR
ABLJU
ABMQK
ABNWP
ABPLI
ABQBU
ABQSL
ABSXP
ABTEG
ABTKH
ABTMW
ABULA
ABWNU
ABXPI
ACAOD
ACBXY
ACDTI
ACGFS
ACHSB
ACHXU
ACKNC
ACMDZ
ACMLO
ACOKC
ACPIV
ACUDM
ACZOJ
ADBBV
ADHIR
ADINQ
ADJJI
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEBTG
AEFQL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFEXP
AFKRA
AFLOW
AFQWF
AFZKB
AGAYW
AGDGC
AGJBK
AGMZJ
AGQEE
AGQMX
AGWZB
AGYKE
AHBYD
AHIZS
AHMBA
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJZVZ
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
B-.
BDATZ
BGNMA
BSONS
BVXVI
CCPQU
CSCUP
DDRTE
DNIVK
DPUIP
EBD
EBLON
EBS
EIOEI
EJD
EMB
EMOBN
ESBYG
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ8
GRRUI
H13
HF~
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
IKXTQ
IMOTQ
IWAJR
IXD
IZIGR
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KOV
LLZTM
M1P
M4Y
MA-
N2Q
NPVJJ
NQJWS
NU0
O93
O9G
O9J
PF0
PQQKQ
PROAC
PSQYO
PT4
QOR
R89
RIG
ROL
RSV
S16
SAP
SCLPG
SDE
SHX
SISQX
SJYHP
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZ9
SZN
TSG
TUC
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VFIZW
W23
W48
YLTOR
ZMTXR
ZOVNA
~EX
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ACSTC
ADHKG
AEZWR
AFDZB
AFHIU
AFOHR
AGQPQ
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
PHGZM
PHGZT
CGR
CUY
CVF
ECM
EIF
NPM
7XB
8AO
8FK
ABRTQ
ABUWG
BENPR
FYUFA
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
7X8
PUEGO
ID FETCH-LOGICAL-c372t-e98779cef8f18a6e10c5738460e7c9f2aae24c7c371fdafe8f04d30ac44eec413
IEDL.DBID AGYKE
ISSN 2194-7228
2194-7236
IngestDate Thu Sep 04 22:39:08 EDT 2025
Fri Jul 25 10:32:00 EDT 2025
Wed Feb 19 02:41:06 EST 2025
Thu Apr 24 22:52:15 EDT 2025
Tue Jul 01 03:47:03 EDT 2025
Fri Feb 21 02:25:58 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords Disease activity
Nephrolithiasis
Recurrent
Kinship coefficient
Familiality
Idiopathic calcium stones
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c372t-e98779cef8f18a6e10c5738460e7c9f2aae24c7c371fdafe8f04d30ac44eec413
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMID 27942796
PQID 1955567776
PQPubID 326290
PageCount 9
ParticipantIDs proquest_miscellaneous_1852662368
proquest_journals_1955567776
pubmed_primary_27942796
crossref_citationtrail_10_1007_s00240_016_0955_9
crossref_primary_10_1007_s00240_016_0955_9
springer_journals_10_1007_s00240_016_0955_9
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20171200
2017-12-00
2017-Dec
20171201
PublicationDateYYYYMMDD 2017-12-01
PublicationDate_xml – month: 12
  year: 2017
  text: 20171200
PublicationDecade 2010
PublicationPlace Berlin/Heidelberg
PublicationPlace_xml – name: Berlin/Heidelberg
– name: Germany
– name: Heidelberg
PublicationSubtitle Urolithiasis
PublicationTitle Urolithiasis
PublicationTitleAbbrev Urolithiasis
PublicationTitleAlternate Urolithiasis
PublicationYear 2017
Publisher Springer Berlin Heidelberg
Springer Nature B.V
Publisher_xml – name: Springer Berlin Heidelberg
– name: Springer Nature B.V
References Jaggi, Nakagawa, Zipperle, Hess (CR20) 2007; 35
Guerra, Folesani, Nouvenne, Ticinesi, Allegri, Pinelli, Prati, Morelli, Guida, Aloe, Meschi (CR5) 2016; 29
Eisner, Sheth, Dretler, Herrick, Pais (CR19) 2012; 80
Vezzoli, Soldati, Gambaro (CR9) 2008; 179
Liu, Chen, Li, Ma, Tong, Lei, Qi (CR10) 2014; 42
Edvardsson, Palsson, Indridason, Thorvaldsson, Stefansson (CR14) 2009; 43
Curhan, Willett, Rimm, Stampfer (CR4) 1997; 8
Mardis, Parks, Muller, Ganzel, Coe (CR18) 2004; 171
Baumann, Affolter (CR21) 2014; 3
CR16
Strauss, Coe, Parks (CR17) 1982; 142
Guerra, Ticinesi, Allegri, Nouvenne, Pinelli, Folesani, Lauretani, Maggio, Borghi, Meschi (CR6) 2016; 44
Trinchieri, Mandressi, Luongo, Coppi, Pisani (CR2) 1988; 139
Resnick, Pridgen, Goodman (CR1) 1968; 278
Nouvenne, Ticinesi, Allegri, Guerra, Guida, Morelli, Borghi, Meschi (CR13) 2014; 52
Gambaro, Marchini, Piccoli, Nassuato, Bilora, Baggio (CR3) 1996; 7
Vezzoli, Terranegra, Aloia, Arcidiacono, Milanesi, Mosca, Mingione, Spotti, Cusi, Hou, Hendy, Soldati, Network (CR11) 2013; 98
Goldfarb, Fisher, Keich, Goldberg (CR8) 2005; 67
Rule, Lieske, Li, Melton, Krambeck, Bergstralh (CR7) 2014; 25
Gambaro, Vezzoli, Casari, Rampoldi, D’Angelo, Borghi (CR12) 2004; 44
Pak (CR15) 1982; 127
A Guerra (955_CR5) 2016; 29
955_CR16
A Nouvenne (955_CR13) 2014; 52
AL Strauss (955_CR17) 1982; 142
G Gambaro (955_CR12) 2004; 44
G Vezzoli (955_CR11) 2013; 98
HK Mardis (955_CR18) 2004; 171
AD Rule (955_CR7) 2014; 25
W Liu (955_CR10) 2014; 42
M Jaggi (955_CR20) 2007; 35
DS Goldfarb (955_CR8) 2005; 67
A Trinchieri (955_CR2) 1988; 139
G Vezzoli (955_CR9) 2008; 179
BH Eisner (955_CR19) 2012; 80
G Gambaro (955_CR3) 1996; 7
A Guerra (955_CR6) 2016; 44
VO Edvardsson (955_CR14) 2009; 43
JM Baumann (955_CR21) 2014; 3
GC Curhan (955_CR4) 1997; 8
M Resnick (955_CR1) 1968; 278
CYC Pak (955_CR15) 1982; 127
26296722 - J Nephrol. 2016 Oct;29(5):645-51
23864702 - J Clin Endocrinol Metab. 2013 Sep;98(9):3839-47
8724895 - J Am Soc Nephrol. 1996 Apr;7(4):608-12
27456839 - J Nephrol. 2016 Dec;29(6):715-734
15558518 - Am J Kidney Dis. 2004 Dec;44(6):963-86
7065787 - Arch Intern Med. 1982 Mar;142(3):504-7
15698445 - Kidney Int. 2005 Mar;67(3):1053-61
17345077 - Urol Res. 2007 Apr;35(2):55-62
7086982 - J Urol. 1982 May;127(5):855-8
25374820 - World J Nephrol. 2014 Nov 6;3(4):256-67
19921989 - Scand J Urol Nephrol. 2009;43(5):420-4
18343451 - J Urol. 2008 May;179(5):1676-82
9335385 - J Am Soc Nephrol. 1997 Oct;8(10):1568-73
22921696 - Urology. 2012 Oct;80(4):776-9
25104803 - J Am Soc Nephrol. 2014 Dec;25(12):2878-86
24190699 - Urolithiasis. 2014 Feb;42(1):45-52
14665850 - J Urol. 2004 Jan;171(1):85-8
3343730 - J Urol. 1988 Mar;139(3):478-81
5648597 - N Engl J Med. 1968 Jun 13;278(24):1313-8
24423579 - Clin Chem Lab Med. 2014 Mar;52(3):337-44
27038481 - Urolithiasis. 2016 Nov;44(6):521-528
References_xml – volume: 42
  start-page: 45
  year: 2014
  end-page: 52
  ident: CR10
  article-title: Vitamin D receptor gene (VDR) polymorphisms and the urolithiasis risk: an updated meta-analysis based on 20 case–control studies
  publication-title: Urolithiasis
  doi: 10.1007/s00240-013-0619-y
– volume: 7
  start-page: 608
  year: 1996
  end-page: 612
  ident: CR3
  article-title: The abnormal red-cell oxalate transport is a risk factor for idiopathic calcium nephrolithiasis: a prospective study
  publication-title: J Am Soc Nephrol
– volume: 44
  start-page: 963
  issue: 6
  year: 2004
  end-page: 986
  ident: CR12
  article-title: Genetics of hypercalciuria and calcium nephrolithiasis: from the rare monogenic to the colon polygenic forms
  publication-title: Am J Kidney Dis
  doi: 10.1053/j.ajkd.2004.06.030
– volume: 139
  start-page: 478
  year: 1988
  end-page: 481
  ident: CR2
  article-title: Familial aggregation of renal calcium stone disease
  publication-title: J Urol
  doi: 10.1016/S0022-5347(17)42497-9
– volume: 44
  start-page: 521
  year: 2016
  end-page: 528
  ident: CR6
  article-title: The influence of maternal and paternal history on stone composition and clinical course of calcium nephrolithiasis in subjects aged between 15 and 25
  publication-title: Urolithiasis
  doi: 10.1007/s00240-016-0878-5
– volume: 43
  start-page: 420
  issue: 5
  year: 2009
  end-page: 424
  ident: CR14
  article-title: Familiality of kidney stone disease in Iceland
  publication-title: Scand J Urol Nephrol
  doi: 10.3109/00365590903151479
– volume: 98
  start-page: 3839
  year: 2013
  end-page: 3847
  ident: CR11
  article-title: Decreased transcriptional activity of calcium-sensing receptor gene promoter 1 is associated with calcium nephrolithiasis
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2013-1834
– volume: 80
  start-page: 776
  year: 2012
  end-page: 779
  ident: CR19
  article-title: Abnormalities of 24-hour urine composition in first-time and recurrent stone-formers
  publication-title: Urology
  doi: 10.1016/j.urology.2012.06.034
– volume: 179
  start-page: 1676
  year: 2008
  end-page: 1682
  ident: CR9
  article-title: Update on primary hypercalciuria from a genetic perspective
  publication-title: J Urol
  doi: 10.1016/j.juro.2008.01.011
– volume: 142
  start-page: 504
  issue: 3
  year: 1982
  end-page: 507
  ident: CR17
  article-title: Formation of a single calcium stone of renal origin. Clinical and laboratory characteristics of patients
  publication-title: Arch Intern Med
  doi: 10.1001/archinte.1982.00340160084019
– volume: 3
  start-page: 256
  issue: 4
  year: 2014
  end-page: 267
  ident: CR21
  article-title: From crystalluria to kidney stones, some physicochemical aspects of calcium nephrolithiasis
  publication-title: World J Nephrol
  doi: 10.5527/wjn.v3.i4.256
– ident: CR16
– volume: 171
  start-page: 85
  issue: 1
  year: 2004
  end-page: 88
  ident: CR18
  article-title: Outcome of metabolic evaluation and medical treatment for calcium nephrolithiasis in a private urological practice
  publication-title: J Urol
  doi: 10.1097/01.ju.0000099789.99127.6b
– volume: 35
  start-page: 55
  issue: 2
  year: 2007
  end-page: 62
  ident: CR20
  article-title: Tamm-Horsfall protein in recurrent calcium kidney stone formers with positive family history: abnormalities in urinary excretion, molecular structure and function
  publication-title: Urol Res
  doi: 10.1007/s00240-007-0083-7
– volume: 25
  start-page: 2878
  year: 2014
  end-page: 2886
  ident: CR7
  article-title: The ROKS nomogram for predicting a second symptomatic stone episode
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.2013091011
– volume: 67
  start-page: 1053
  year: 2005
  end-page: 1061
  ident: CR8
  article-title: A twin study of genetic and dietary influences on nephrolithiasis: a report from the Vietnam Era Twin (VET) Registry
  publication-title: Kidney Int
  doi: 10.1111/j.1523-1755.2005.00170.x
– volume: 8
  start-page: 1568
  year: 1997
  end-page: 1573
  ident: CR4
  article-title: Family history and risk of kidney stones
  publication-title: J Am Soc Nephrol
– volume: 278
  start-page: 1313
  issue: 24
  year: 1968
  end-page: 1318
  ident: CR1
  article-title: Genetic predisposition to formation of calcium oxalate renal calculi
  publication-title: N Engl J Med
  doi: 10.1056/NEJM196806132782403
– volume: 52
  start-page: 337
  issue: 3
  year: 2014
  end-page: 344
  ident: CR13
  article-title: Twenty-five years of idiopathic calcium nephrolithiasis: has anything changed?
  publication-title: Clin Chem Lab Med
  doi: 10.1515/cclm-2013-0618
– volume: 127
  start-page: 855
  year: 1982
  end-page: 859
  ident: CR15
  article-title: Should patients with single renal stone occurrence undergo diagnostic evaluation?
  publication-title: J Urol
  doi: 10.1016/S0022-5347(17)54106-3
– volume: 29
  start-page: 645
  year: 2016
  end-page: 651
  ident: CR5
  article-title: Family history influences clinical course of idiopathic calcium nephrolithiasis: case–control study of a large cohort of Italian patients
  publication-title: J Nephrol
  doi: 10.1007/s40620-015-0225-x
– volume: 52
  start-page: 337
  issue: 3
  year: 2014
  ident: 955_CR13
  publication-title: Clin Chem Lab Med
  doi: 10.1515/cclm-2013-0618
– volume: 127
  start-page: 855
  year: 1982
  ident: 955_CR15
  publication-title: J Urol
  doi: 10.1016/S0022-5347(17)54106-3
– volume: 3
  start-page: 256
  issue: 4
  year: 2014
  ident: 955_CR21
  publication-title: World J Nephrol
  doi: 10.5527/wjn.v3.i4.256
– volume: 98
  start-page: 3839
  year: 2013
  ident: 955_CR11
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2013-1834
– volume: 171
  start-page: 85
  issue: 1
  year: 2004
  ident: 955_CR18
  publication-title: J Urol
  doi: 10.1097/01.ju.0000099789.99127.6b
– volume: 43
  start-page: 420
  issue: 5
  year: 2009
  ident: 955_CR14
  publication-title: Scand J Urol Nephrol
  doi: 10.3109/00365590903151479
– volume: 35
  start-page: 55
  issue: 2
  year: 2007
  ident: 955_CR20
  publication-title: Urol Res
  doi: 10.1007/s00240-007-0083-7
– volume: 142
  start-page: 504
  issue: 3
  year: 1982
  ident: 955_CR17
  publication-title: Arch Intern Med
  doi: 10.1001/archinte.1982.00340160084019
– volume: 44
  start-page: 963
  issue: 6
  year: 2004
  ident: 955_CR12
  publication-title: Am J Kidney Dis
  doi: 10.1053/j.ajkd.2004.06.030
– ident: 955_CR16
  doi: 10.1007/s40620-016-0329-y
– volume: 44
  start-page: 521
  year: 2016
  ident: 955_CR6
  publication-title: Urolithiasis
  doi: 10.1007/s00240-016-0878-5
– volume: 139
  start-page: 478
  year: 1988
  ident: 955_CR2
  publication-title: J Urol
  doi: 10.1016/S0022-5347(17)42497-9
– volume: 278
  start-page: 1313
  issue: 24
  year: 1968
  ident: 955_CR1
  publication-title: N Engl J Med
  doi: 10.1056/NEJM196806132782403
– volume: 29
  start-page: 645
  year: 2016
  ident: 955_CR5
  publication-title: J Nephrol
  doi: 10.1007/s40620-015-0225-x
– volume: 7
  start-page: 608
  year: 1996
  ident: 955_CR3
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.V74608
– volume: 8
  start-page: 1568
  year: 1997
  ident: 955_CR4
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.V8101568
– volume: 25
  start-page: 2878
  year: 2014
  ident: 955_CR7
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.2013091011
– volume: 67
  start-page: 1053
  year: 2005
  ident: 955_CR8
  publication-title: Kidney Int
  doi: 10.1111/j.1523-1755.2005.00170.x
– volume: 179
  start-page: 1676
  year: 2008
  ident: 955_CR9
  publication-title: J Urol
  doi: 10.1016/j.juro.2008.01.011
– volume: 42
  start-page: 45
  year: 2014
  ident: 955_CR10
  publication-title: Urolithiasis
  doi: 10.1007/s00240-013-0619-y
– volume: 80
  start-page: 776
  year: 2012
  ident: 955_CR19
  publication-title: Urology
  doi: 10.1016/j.urology.2012.06.034
– reference: 24190699 - Urolithiasis. 2014 Feb;42(1):45-52
– reference: 19921989 - Scand J Urol Nephrol. 2009;43(5):420-4
– reference: 23864702 - J Clin Endocrinol Metab. 2013 Sep;98(9):3839-47
– reference: 8724895 - J Am Soc Nephrol. 1996 Apr;7(4):608-12
– reference: 15698445 - Kidney Int. 2005 Mar;67(3):1053-61
– reference: 26296722 - J Nephrol. 2016 Oct;29(5):645-51
– reference: 5648597 - N Engl J Med. 1968 Jun 13;278(24):1313-8
– reference: 14665850 - J Urol. 2004 Jan;171(1):85-8
– reference: 9335385 - J Am Soc Nephrol. 1997 Oct;8(10):1568-73
– reference: 25374820 - World J Nephrol. 2014 Nov 6;3(4):256-67
– reference: 27456839 - J Nephrol. 2016 Dec;29(6):715-734
– reference: 15558518 - Am J Kidney Dis. 2004 Dec;44(6):963-86
– reference: 24423579 - Clin Chem Lab Med. 2014 Mar;52(3):337-44
– reference: 7065787 - Arch Intern Med. 1982 Mar;142(3):504-7
– reference: 27038481 - Urolithiasis. 2016 Nov;44(6):521-528
– reference: 18343451 - J Urol. 2008 May;179(5):1676-82
– reference: 22921696 - Urology. 2012 Oct;80(4):776-9
– reference: 3343730 - J Urol. 1988 Mar;139(3):478-81
– reference: 25104803 - J Am Soc Nephrol. 2014 Dec;25(12):2878-86
– reference: 7086982 - J Urol. 1982 May;127(5):855-8
– reference: 17345077 - Urol Res. 2007 Apr;35(2):55-62
SSID ssj0000999410
Score 2.1765404
Snippet The role of the strength of family history of stones (FHS), i.e., degree of relatives with the disease, on the course of calcium urolithiasis (CU) is not fully...
SourceID proquest
pubmed
crossref
springer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 525
SubjectTerms Adolescent
Adult
Age Factors
Calcium - metabolism
Calcium - urine
Cross-Sectional Studies
Family medical history
Female
Humans
Kidney Calculi - epidemiology
Kidney Calculi - etiology
Kidney Calculi - urine
Male
Medical Biochemistry
Medical History Taking - statistics & numerical data
Medicine
Medicine & Public Health
Metabolism
Nephrology
Original Paper
Recurrence
Renal Elimination
Retrospective Studies
Risk Factors
Sex Factors
Urology
Young Adult
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3Ni9UwEA-6gngRv326ygielGCTpk3rRWRxWYT15MK7lWmauIW37bptD-8f8O92pl8qi3vooXTShk4m88t8CvHWxiEkHlGGgFoaLJ3EtAxScVBYFDJfRZycfPotPTkzX7fJdja4dXNY5bInjht11Tq2kX9QeZIkqbU2_XT5U3LXKPauzi00bos7ipAIt26wW7vaWBj9mLEgAcmlkVbrbHFsRmMdUc2xjYqO1PRymf-rmq7hzWu-0lEFHT8Q92fsCJ8nZj8Ut3zzSNw9nb3jj8WvI9y5eriAgVvx9Oc1dnUHruU4Dagb2LNkA6M9D4xVCfkBEdRLn5IKyj0QIAROIGl-9OfQBpgsIDDVJd5_BDqeD7u-A85LAaTb_qpd0jVhLFb7RJwdf_l-dCLnPgvSxVb30ueZtbnzIQsqw9SryCU2JmASeevyoBG9Ns4SsQoVBp-FyFRxhM4Y7x1pwafioKGpPxdA0kzqjjOlK2VoLIYSS9QxpkjIQCUbES2_uHBzEXLuhbEr1vLJI1cKDjxjrhT5Rrxbh1xOFThuIj5c-FbMwtgVf5bORrxZH5MYsW8EG98ORJMlBFV0nGYb8Wzi9_o1TXsWXTT6_bIA_nr5_6by4uapvBT3NCOEMTLmUBz0V4N_RfimL1-Pi_g3oN35HQ
  priority: 102
  providerName: ProQuest
Title Calcium urolithiasis course in young stone formers is influenced by the strength of family history: results from a retrospective study
URI https://link.springer.com/article/10.1007/s00240-016-0955-9
https://www.ncbi.nlm.nih.gov/pubmed/27942796
https://www.proquest.com/docview/1955567776
https://www.proquest.com/docview/1852662368
Volume 45
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELZoKyEuUN4LpRokTiBXiWPHCbe2aqlArRBqpeUUTRybRt1mUZMclh_A72acF48CUg9RFHnsOM6M_dnzYuyVjpxTFpE7h4JLzA3HOHc89EZhgUtsEXjn5OOT-OhMvp-r-eDHXY_W7qNKspupJ2e3LhwXbX1pB5wqxdM1tqFof0LSuLH77vOHn0crHvTILg4BiaPkWohk1Gf-rZ3fV6RrMPOairRbeQ7vsdOxz73BycVO2-Q75tsf4Rxv-FGb7O6ARGG3Z5377JatHrDbx4Ou_SH7vo8LU7aX0PrEPs15iXVZg1l6qw8oK1j5eQI8drTgkS_hSCCCcsx6UkC-AoKX4N1Rqi_NOSwd9Ocp0Ec5Xr0F2uy3i6YG7-UCSI_N1XJ0_oQu9O0jdnZ4cLp_xIesDdxEWjTcponWqbEucWGCsQ0Do3REMCew2qROIFohjSbi0BXobOICWUQBGimtNbSmPmbrFXX9KQOaG2jx9H7XRSipLroccxQRxkg4I1QzFox_LjNDSHOfWWORTcGYu_HNvBmbH98snbHXU5WvfTyP_xFvjeyQDaJdZyEVqVhrHc_Yy6mYhNJrWrCyy5ZoEkXAR0RxMmNPejaa3iZoBqSLar8ZWeKXxv_VlWc3on7O7ggPPzqzmy223ly19gWBpybfZmt6rrcHkaH73sHJx08_AGjkFNg
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELbKVgIuiDcLBQYJLiCLxHHiBKlCUFptaXeFUCv1FhzHppGW3bJJhPYP8LP4bczkBaiitx5yiDJOHI8989nzYuy5CpwLrdbcOS241JnhOsoc98kpzHOxzT0KTp7Oosmx_HgSnmywX30sDLlV9jKxEdT50tAZ-Ws_CcMwUkpFb8--c6oaRdbVvoSG7kor5NtNirEusOPArn_gFq7c3v-A_H4hxN7u0c6Ed1UGuAmUqLjFXbdKjHWx82MdWd8zoQpQLXtWmcQJra2QRiGx73LtbOw8mQeeNlJaa1AH4HuvsE1JBygjtvl-d_bp83DKQ_hLNikRUDJIroSIe9Oq12QyFeRd6eOmHn-PJ_8qx3OI95y1tlGCezfZjQ69wrt2ut1iG3Zxm12ddvb5O-znjp6bov4GNRUDqk4LXRYl4KCtSgvFAtYkW4DwpgVCy4g9AQmKvlJKDtkaEJIChbAsvlansHTQnsFAmxl5_QZWtqznVQkUGQMab6vVsg8YhSZd7l12fCk8uMdGC-z6AwYoT1DhUqx27ktsq12mMy0CHWnEJn44Zl4_xKnp0qBTNY55OiRwbriSkusbcSVNxuzl0OSszQFyEfFWz7e0Ewdl-mfyjtmz4TEuZLLO6IVd1kgThwiWRBDFY3a_5ffwNYFSEy9s_aqfAH-9_H9deXhxV56ya5Oj6WF6uD87eMSuC8IrjZ_OFhtVq9o-RrRVZU-6KQ3sy2Wvot9_oD4O
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKK1VcEG-2FBgkuICiJs7DCVKFoO2qpXRVISr1lk4cm0ZadttNIrR_gB_Hr2ImL0AVvfWQQxQ7cTz2zDeelxCvlG9taBAda1E6AWbawSizjsdOYa6NTe5ycPLRJNo_CT6dhqcr4lcfC8NulT1PbBh1Ptd8Rr7lJWEYRkqpaMt2bhHHu-P3F5cOV5BiS2tfTgO7Mgv5dpNurAvyODTLH6TOldsHu0T711KO977u7DtdxQFH-0pWjiENXCXa2Nh6MUbGc3WofBLRrlE6sRLRyEArauzZHK2JrRvkvos6CIzRJA_ovbfEmiKpT4rg2se9yfGX4cSHsVjQpEcgLhE4Ssq4N7O6TVZTyZ6WHin49KtO8q-gvIJ-r1huG4E4vivudEgWPrRL755YMbP7Yv2os9U_ED93cKqL-jvUXBioOi-wLEqgSVuUBooZLJnPAGNPA4ycCYcCNSj6qik5ZEsgeAoczjL7Vp3D3EJ7HgNtluTlO1iYsp5WJXCUDCDdVot5HzwKTerch-LkRmjwSKzOaOhPBBBvIeHLcdu5F1BftBlmKH2MkHCKF46E209xqruU6FyZY5oOyZwbqqTsBsdUSZOReDN0uWjzgVzXeLOnW9qxhjL9s5BH4uXwmDY1W2pwZuY1tYlDAk7Sj-KReNzSe_iaJA5KF_V-2y-Av17-v6FsXD-UF2KddlP6-WBy-FTclgxdGpedTbFaLWrzjIBXlT3vVjSIs5veRL8Bcv1CUg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Calcium+urolithiasis+course+in+young+stone+formers+is+influenced+by+the+strength+of+family+history%3A+results+from+a+retrospective+study&rft.jtitle=Urolithiasis&rft.au=Guerra%2C+Angela&rft.au=Ticinesi%2C+Andrea&rft.au=Allegri%2C+Franca&rft.au=Nouvenne%2C+Antonio&rft.date=2017-12-01&rft.pub=Springer+Berlin+Heidelberg&rft.issn=2194-7228&rft.eissn=2194-7236&rft.volume=45&rft.issue=6&rft.spage=525&rft.epage=533&rft_id=info:doi/10.1007%2Fs00240-016-0955-9&rft.externalDocID=10_1007_s00240_016_0955_9
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2194-7228&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2194-7228&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2194-7228&client=summon